baber/WOPTO huggingface dataset:
Patent NZ-513423-A (NZ)
Title: Compositions and methods for the treatment of tumors
Inventor: BOTSTEIN DAVID
IPC: C12N15/11
Filed: 1999-12-02
Abstract: Antibodies that bind to PRO3567, PRO4344 or PRO4397 polypeptide; the use of said polypeptides in diagnosing tumours, wherein the expression level of genes encoding said polypeptides in a test sample is compared to a control sample, higher expression in the test sample indicative of the presence of tumours; also disclosed is the use of anti-PRO3567, anti-PRO4344 or anti-PRO4397 antibodies for inhibiting the growth of tumour cells. Further disclosed is a method of identifying compounds that inhibit the activity/expression of a PRO3567, PRO4344 or PRO4397 polypeptide.
Patent NZ-514652-A (NZ)
Title: Methods of treating schizophrenia using dopamine or dopamine precursor producing cells within a support matrix
Inventor: ALLEN RICHARD C
IPC: A61K35/12
Filed: 2000-03-20
Abstract: Disclosed are methods for the treatment of abnormal psychiatric states, particularly the negative symptoms of schizophrenia and extrapyramidal side effects (EPS) of antipsychotic drugs. These methods relate to the administration of therapeutic cells (which produce dopamine or dopamine precursors) adhered to support matrices to subjects suffering from the negative symptoms of schizophrenia and/or EPS. The therapeutic cells may be co-administered with cells which protect the therapeutic cells from immune rejection and/or cells which produce neurotrophic factors which improve the viability of the therapeutic cells.
Patent NZ-516843-A (NZ)
Title: Heat and roller apparatus to provide double faced batt, with batt longitudinal pre-slicing mechanism
Inventor: PATEL BHARAT D
IPC: D04H13/00
Filed: 2000-07-05
Abstract: Facing material 64,100 is applied to respective  faces of  batts  that  have been split longitudinally  by  a  pre- slicing mechanism (not shown).
Patent NZ-517495-A (NZ)
Title: Detonator
Inventor: DUMENKO VIKTOR
IPC: C06C7/00
Filed: 2000-08-31
Abstract: An initiating element (5) for use in a detonator (1) to cause a base charge (2), arranged in the detonator, to detonate comprises; an ignitable initiating charge (9, 10), which upon ignition generates combustion gases by means of which the base charge is intended to detonate, and a compression means (7), which is arranged to be moved towards the base charge by said combustion gases for compression of the base charge. The base charge is compressed during an initiation phase to increased density and is such that at a moment of detonation has increased density.
Patent NZ-520067-A (NZ)
Title: Underwater signalling devices
Inventor: KATZ PETER
IPC: B63C11/26
Filed: 2000-12-08
Abstract: A signalling device (10) adapted to make a percussive sound, for example, under water. The signalling device may be attached to a pressurised fluid source, such as a diver's compressed air supply, the device including: a housing (12) having a passageway (22), at least in part, for communication with the fluid source; a valve member (34) located in the passageway and movable between a closed position in which it substantially blocks the passageway, and an open position in which fluid may flow through the passageway; biasing means (42), such as a spring, biasing the valve member towards the closed position, wherein the valve member reciprocates between the open and closed positions when a pressure difference above a set value exists on either of the valve member to produce a perscussive sound.
Patent NZ-521365-A (NZ)
Title: gM-negative EHV-mutants
Inventor: ELBERS KNUT
IPC: A61K39/245
Filed: 2001-02-15
Abstract: An isolated or partially isolated Equine Herpes Virus is disclosed. The protein gM is essentially absent to the extent that only the region of overlap with the UL9 homologue is present in the virus. This Equine Herpes Virus is also disclosed as being useful in a medicament for the prophylaxis or treatment of an animal.
Patent NZ-522934-A (NZ)
Title: Single-document active user interface, method and system for implementing same
Inventor: STIEGEMEIER MARK R
IPC: G06F9/44
Filed: 1998-10-02
Abstract: A method of entering, storing, displaying, and retrieving data using a data management system having a display device, one or more input devices, and a storage device comprises: (1) entering, by the user, a plurality of the data including multiple groups with multiple entries of data for a substantially same field or substantially same set of fields; (2) managing, by the data management system, the plurality of the data including the multiple groups with the multiple entries of data in at least one of a single document, single logical document and file, by maintaining each of the multiple entries directly after each other corresponding with each of the multiple groups; and (3) displaying only the field in the substantially same field or the substantially same set of fields corresponding to the entry selected by the user.
Patent NZ-525878-A (NZ)
Title: A method of treating nicotine dependance with mecamylamine
Inventor: MIRANDA J
IPC: A61K31/465
Filed: 1999-12-07
Abstract: A transdermal patch for administering a volatile liquid drug, such as nicotine, transdermally to a patient comprising a four-layer laminated composite of: a top drug impermeable backing layer; a pressure sensitive silicone adhesive layer containing the drug; a pressure sensitive acrylic adhesive layer also containing the drug; and a removable siliconized release liner layer. Also disclosed is a method for treating a person for nicotine dependence and particularly for treating a woman for nicotine dependence.
Patent NZ-530008-A (NZ)
Title: Method and apparatus for gas induced mixing and blending of fluids and other materials
Inventor: PARKS RICHARD E
IPC: B01F33/40
Filed: 2002-05-06
Abstract: An injector system is disclosed including an injector operatively connected to a source of pressurized gas and mounted to an accumulator located in close proximity to the bottom of a tank containing a fluid or other materials. The injector comprises a chamber housing and a valve disposed in the chamber housing. The chamber housing is able to be mated to an accumulator that defines an orifice, and receives pressuzired gas from an external source. The valve engages the accumulator and selectively administers or obstructs the release of the gas into the tank as directed by an actuator contained within the chamber housing. In ambient environments that tend to fool and clog the chamber orifice or accumulator orifice, a removable orifice plate is used wherein the valve engages the orifice plate.
Patent NZ-531735-A (NZ)
Title: Flooring and method for laying and manufacturing the same
Inventor: PERVAN DARKO
IPC: E04F15/04
Filed: 2002-09-20
Abstract: Floorboards for installation of floors in herring-bone pattern are formed with two opposite sides inverted relative to each other. The invention further comprises methods for producing and making floorings comprising such floorboards, as well as fitting pieces and sets of parts for such floorings.
Patent NZ-537760-A (NZ)
Title: Worming formulations comprising a macrocyclic lactone and piperonyl butoxide
Inventor: MARTIN PAUL JOHN
IPC: A61K31/365
Filed: 2003-06-26
Abstract: Disclosed is a formulation comprising a macrocyclic lactone, together with an amount of piperonyl butoxide when used as a veterinary worming formulation. Also disclosed is the use of a formulation comprising and effective amount of a macrocyclic lactone, together with an amount of piperonyl butoxide in the manufacture of a medicament for the prevention or treatment of anthelmintic infections in mammals.
Patent NZ-539611-A (NZ)
Title: Attachable sensor for putting stroke path and plane detection
Inventor: SHERMAN ROBYN ANN
IPC: A63B57/00
Filed: 2003-10-03
Abstract: A putter trainer device for detecting inaccuracies in a golf putting stroke is disclosed. The putting trainer device is releasably attached by a clip (2) to a shaft of a golf putter and includes two guided ramps (19A, 19B) with each ramp having an active position and a neutral position. In one embodiment, a free rolling disc magnet (20A, 20B) is located upon each guided ramp and each free rolling disc magnet is biased towards the neutral position (23A, 23B) on its respective ramp. The movement of either free rolling magnet from the neutral position to the active position is detected by magnetic reed switches (25A, 25B) located adjacent to each ramp. A speaker is activated when the magnetic reed switches detect that either free rolling magnet has moved from the neutral position to the active position.
Patent NZ-540103-A (NZ)
Title: Process for producing macrolide compound
Inventor: OKUDA AKIFUMI
IPC: A61P35/00
Filed: 2003-11-27
Abstract: Disclosed is a method of producing the macrolide compound 11107D represented by the formula (II) wherein the macrolide compound 11107D is produced from the macrolide compound 1107B represented by the formula (I) by a biological transformation method, which comprises the following processes (A) and (B): (A) a process of incubating the macrolide compound 11107B represented by the formula (I) in the presence of a strain having an ability of conducting the above-mentioned transformation method and belonging to the genus Mortierella, the genus Streptomyces or the family Micromonosporaceae or a preparation of its cultured mycelia; and (B) a process of collecting the macrolide compound 11107D represented by the formula (II) from the incubated solution obtained in the step (A). Also disclosed are specific strains having the ability of transforming the macrolide compound 11107B into 11107D.
Patent NZ-540684-A (NZ)
Title: Authenticating images identified by a software application
Inventor: LANGFORD RONALD NEVILLE
IPC: G06F17/30
Filed: 2005-06-13
Abstract: A method and system for authenticating link information related to an image 805. The system 800 checks the image 805 and if it contains internet link information then the image is passed through a verification step. The image is decoded using public encryption key 845 to extract original image 720 and ciphertext 750. Two reference images 740, 850 are produced by decoding the ciphertext and encoding the original image. If the reference images 740, 850 match then the link image 805 is authenticated and the embedded internet link 730 is provided to the user. If the images do not match the system will either reject and not display the link image or provide the user with a warning that the image has not been authenticated. The system provides security against fraudulent web sites which have the appearance of being a legitimate site by the use of copied logos and images.
Patent NZ-543319-A (NZ)
Title: Compositions and methods for treating amyloidosis using sulphonate derivatives
Inventor: GORDON HEATHER
IPC: A61K31/192
Filed: 2000-04-28
Abstract: Disclosed is the use of compounds of the formula I in compositions for inhibiting, preventing and treating amyloid aggregation, e.g. in pancreatic islets wherein the amyloidotic aggregates to be treated are in an embodiment, islet amyloid polypeptide (IAPP)-associated amyloid aggregates, e.g. having at least some beta-sheet structure. Accordingly, the compositions and compounds are useful for inhibiting amyloidosis in disorders in which such amyloid aggregation occurs e.g. Alzheimer's disease.
Patent NZ-543803-A (NZ)
Title: Winding tube
Inventor: QUICK DIETER
IPC: B65H75/18
Filed: 2004-05-25
Abstract: The invention relates to a winding tube (9) for receiving a strip-shaped finished or half-finished product comprising an elongated cylindrical body (10) provided with an internal wall (11) in front of which a contactless readable data carrier containing data on said strip-shaped finished or half-finished product is arranged. In order to produce the inventive multi-purpose winding (9) tube at low cost and provide it with excellent operating and recycling characteristics, said data carrier is hold in the tube body by means of a tubular holding element (1) in such a way that it is placed at a certain distance from the internal wall of the tube body.
Patent NZ-550810-A (NZ)
Title: High affinity NY-ESO T cell receptor
Inventor: BOULTER JONATHAN MICHAEL
IPC: A61K35/12
Filed: 2005-05-18
Abstract: Disclosed is a T-cell receptor (TCR) having the property of binding to SLLMWlTQC-HLA-A*0201 and comprising at least one TCR a chain variable domain and/or at least one TCR beta-chain variable domain characterised in that said TCR (i) is mutated relative to the native 104 TCR alpha chain variable domain (SEQ 10 No: 1) and/or beta-chain variable domain (SEQ 10 NO: 2) in at least one complementarity determining region or in at least one variable domain framework region thereof, and (ii) has a KD for the said SLLMWlTQC-HLA-A*0201 complex of less than or equal to 1microM and/or has an off-rate (koff) for the SLLMWlTQC-HLA-A*0201 complex of 1x10-3 S-1 or slower. Also disclosed is the use of the TCR described above in the treatment of cancer.
Patent NZ-553508-A (NZ)
Title: Treatment of neoplasms with viruses
IPC: A61K35/76
Filed: 1998-10-09
Abstract: Disclosed is a method of producing viruses for use in antineoplastic therapy comprising modifying an existing virus by diminishing or ablating a viral mechanism for the inactivation of the antiviral effects of IFN comprising mutating at least one viral gene involved with blocking interferon's antiviral activity, wherein the virus is: (i) a vaccinia virus and the at least one viral gene is selected from the group consisting of K3L, E3L and B18R, (ii) a reovirus and the at least one viral gene is an delta gene, (iii) an adenovirus and the at least one viral gene is a VA gene, or (iv) an alphaherpesvirus and the at least one viral gene is a gamma 34.5 gene.
Patent NZ-553701-A (NZ)
Title: Composition comprising SC03-014 and SC03-022 antibodies against SARS-CoV
Inventor: TER MEULEN JAN HENRIK
IPC: A61P31/12
Filed: 2005-11-10
Abstract: Disclosed is a composition comprising at least two immunoglobulins that are capable of specifically binding to a SARS-CoV and have SARS-CoV neutralizing activity, wherein a first immunoglobulin comprises a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 4 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 8 or a heavy and light chain variable region having at least 80% sequence homology thereto and still having SARS-CoV binding and neutralizing activity and; wherein a second immunoglobulin comprises a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 6 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 10 or a heavy and light chain variable region having at least 80% sequence homology thereto and still having SARS-CoV binding and neutralizing activity; characterized in that the relative amounts of the immunoglobulins are such that they exhibit a synergistic neutralizing activity.
Patent NZ-554480-A (NZ)
Title: Roller doors with resilient seal that deforms to have little efffect on rolling up of door
Inventor: BROWN NORMAN MATTHEW
IPC: E06B9/17
Filed: 2005-09-07
Abstract: A roller door having a seal means (30) which is attached to the door shutter (22) at a location such that when the door is in its closed condition, the seal extends from the face of the door and extends outwardly therefrom and contacts the door sill (13) and, when the door is opened, the seal means (30) is caused to be located between the portion of the shutter to which it is connected and the portion of the shutter which lies directly thereover, the seal means is of such a form that when so located it has little effect on the form of the rolled shutter. The embodiment shows the seal means being formed of an extrusion of a resilient material which, when unconstrained has a substantial depth extending outwardly of the door but which can reduce to a minimal depth when pressure is applied thereto. The seal means (30) may have extensions along each side which can be received in recesses on the face of the shutter.
Patent NZ-554759-A (NZ)
Title: Single-track stacking panel covering for an architectural opening
Inventor: COLSON WENDELL B
IPC: E05D15/06
Filed: 2005-11-03
Abstract: A single-track stacking panel covering for an architectural opening has a headrail for mounting the covering above and in front of the opening, such as a window or door. The headrail has a single track. Suspended from the headrail and translatable therealong are panels oriented at a small angle relative to the headrail. When the covering is open, the panels form an overlappingly stacked array at one end of the headrail.
Patent NZ-568137-A (NZ)
Title: Method of measuring the affinity of biomolecules
Inventor: DALE TREVOR CLIVE
IPC: B01J19/00
Filed: 2006-11-10
Abstract: Disclosed is a method of measuring the affinity of first and second biomolecules in which a first biomolecule is tethered by a first tether portion having a first tether portion length and a second biomolecule is tethered by a second tether portion having a second tether portion length, determining binding of adjacent first and second biomolecules to each other, varying at least one of the first and second tether portion lengths and determining binding of the first and second biomolecules, wherein the biomolecules are tethered to a support and/or tethered together.
Patent NZ-569604-A (NZ)
Title: Treatment of HIV comprising administering a corticotropin releasing factor (CRF) peptide
Inventor: MCINTOSH DEIRDRE
IPC: A61K38/095
Filed: 2007-01-05
Abstract: Disclosed is the use of a corticotropin releasing factor (CRF) peptide and a POMC peptide or POMC product in the manufacture of a medicament for the treatment of HIV.
Patent NZ-569852-A (NZ)
Title: Method for decorating surfaces by welded a film to a shaped article by using laser radiation
Inventor: WIELPUTZ MARTIN
IPC: B29C65/16
Filed: 2008-07-16
Abstract: A method for the production of a film-coated shaped article is disclosed, in which at least a portion of a surface of the shaped article is welded to a film by using laser radiation; the film has a thickness of between 10 micrometer and 2000 micrometer; and the film or an outward-directed layer of the film includes a moulding material based on semicrystalline polyamide, fluoropolymer, polyester or polyolefin.
Patent NZ-571354-A (NZ)
Title: Polylactide nanoparticles
Inventor: KREUTER JORG
IPC: A61K9/51
Filed: 2007-03-13
Abstract: Disclosed is a method of preparing a drug targeting system for administering a pharmacologically active substance to the central nervous system of a mammal across its blood brain barrier, the method comprising the steps of: a) solubilising poly(DL-lactide) and/or poly(DL-lactide-co-glycolide), at least one pharmacologically active substance, and a liquid compound selected from the group of lipid compounds which consists of cetyl phosphate, potassium cholesteryl sulphate and tocopheryl succinate, in an organic solvent to obtain an organic phase; b) pouring the organic phase into an aqueous solution; c) emulsifying the mixture to obtain a primary emulsion; d) homogenising the primary emulsion; e) removing the organic solvent from the primary emulsion; f) filtering the resulting nanosuspension comprising drug-loaded nanoparticles; and g) coating the nanoparticles with poloxamer 188. Also disclosed is a drug targeting system which comprising nanoparticles made of poly(DL-lactide) and/or poly(DL-lactide-co-glycolide) , and at least one pharmacologically active substance being absorbed to, adsorbed to, and/or incorporated into the nanoparticles, wherein the system comprises a poloxamer 188 surfactant coating deposited on the drug-loaded nanoparticles, and wherein the system has been prepared in accordance with the above method or an analogous method as disclosed herein.
Patent NZ-579038-A (NZ)
Title: Vectors for transformation
Inventor: CONNER ANTHONY JOHN
IPC: C12N15/82
Filed: 2005-09-07
Abstract: A plant transformation vector comprising first and second recombinase recognition sequences, wherein the recombinase recognition sequences are derived from plant species, and are not identical to any recombinase recognition sequences from non-plant species. Further provided are methods of producing transformed plants using the vector and plants or plant cells produced by such methods. (62) Divided Out of 553676
Patent NZ-581637-A (NZ)
Title: Antibodies to OPGL
Inventor: BOYLE WILLIAM J
IPC: A61P19/08
Filed: 2005-06-25
Abstract: Provided are osteoprotegerin ligand (OPGL) binding antibodies with specified heavy and light chain sequences. The antibodies can be used to treat bone loss diseases. Further provided are corresponding nucleotide sequence encoding the antibody and their use in expression vectors to produce the antibody.
Patent NZ-582219-A (NZ)
Title: Methods for isolating long fragment rna from fixed samples
Inventor: DANENBERG KATHLEEN
IPC: C12N15/10
Filed: 2008-06-23
Abstract: Provided is a method for the isolation of long fragment RNA from a fixed tissue sample comprising the following: a) heating the fixed tissue sample in an extraction solution to a temperature in the range of about 44 to about 62° C for a time period of 3 hours or more, where in the extract ion solution comprises a chelator at a concentration of about 0. 1 mM to about 20 mM, and proteinase K; and b) removing DNA contamination by performing at least a first and a second extract ion with a solution comprising phenol and chloroform, wherein the second extraction further comprises a chaotropic agent, to produce an RNA-enriched solution; and c) isolating said RNA from said RNA-enriched solution.
Patent NZ-582541-A (NZ)
Title: Stepwise natural product extraction involving carbon dioxide (CO2) and compressed hydrocarbons
Inventor: KNEZ ZELJKO
IPC: A23L17/00
Filed: 2008-06-13
Abstract: Disclosed is a method for extracting products of value from animal or vegetable starting material, characterised in that soluble constituents are extracted from the starting material in a first extraction step, using a mixture of carbon dioxide, and a polar entraining agent, and subsequently, in a second extraction step, other constituents are extracted with compressed hydrocarbons.
Patent NZ-586959-A (NZ)
Title: Folates, compositions and uses thereof
Inventor: VALOTI ERMANNO
IPC: A61K31/519
Filed: 2008-02-20
Abstract: Disclosed is a crystalline or amorphous compound which is a folate or a reduced folate of D-glucosamine, D-galactosamine, folate, -dihydrofolate, -tetrahydrofolate, unsubstituted or substituted with a 5-methyl-, 5-formyl-, 10-formyl-, 5,10-methylene-, 5,10-methenyl- moiety, the compound, whenever contemplated, being in a (6R,S), (6S) or a (6R) configuration. Use of this crystalline or amorphous compound for the preparation of a medicament, a food additive or a nutritional supplement, for the prevention and/ or the treatment of either deficiencies or diseases positively affected by the administration of both folates and reduced folates is also disclosed, wherein the deficiencies or diseases is selected from neurological affection (such as subacute encephalitis associated with dementia and vacuolar myelopathies); pathopsychological, vascular and cardiovascular conditions (such as premature occlusive arterial disease, severe vascular disease in infancy and childhood, progressive arterial stenosis, intermittent claudication, renovascular hypertension, ischemic cerebrovascular disease, premature retinal artery and retinal vein occlusion, cerebral occlusive arterial disease, occlusive peripheral arterial disease, premature death due to thromboembolic disease and ischemic heart disease); autoimmune diseases (such as psoriasis, celiac disease, arthritic and inflammation conditions); megaloblastic anaemia due to folate deficiency, intestinal malabsorption, for reducing a female's risk of having a miscarriage and/ or of having a fetus with a neural tube defect, a cleft lip defect, and/or a cleft palate defect, for maintaining and/or normalizing the homocysteine level and/or metabolism; alterations of the synthesis and/or the functioning and/or the changes of DNA and RNA and the alterations of cell synthesis; depressive illnesses.